Latest News
FDA/CDC
FDA approves first IV migraine prevention drug
“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine...
Conference Coverage
Should routine colon cancer screening start at 45, not 50?
SAN FRANCISCO — Experts disagree over the age at which to start colorectal cancer screening.
Conference Coverage
Guidance defines vaping-related respiratory syndrome
ORLANDO – The guidance is designed to help critical care professionals efficiently identify those individuals at high risk of respiratory failure...
Conference Coverage
Medicare beneficiaries get few home health visits after ICU stay
ORLANDO – The beneficiaries received an average of less than one visit per week in the month after ICU discharge, while a third received no visits...
Conference Coverage
Opioid use disorder up in sepsis hospitalizations
ORLANDO – “While we don’t necessarily screen every sepsis patient for endocarditis, if it’s an opioid use disorder patient – particularly one with...
FDA/CDC
FDA opens the door to biosimilar insulin
The agency published a final rule that transitions insulin and other products from regulation as a drug to a biologic.
Conference Coverage
First clinical evidence of neuroprotection in acute stroke?
LOS ANGELES – A potential neuroprotectant was beneficial for patients with ischemic stroke undergoing thrombectomy in the ESCAPE-NA1 trial.
News
Tumor neoantigenicity metric improves prediction of response to immunotherapy
A new scoring system can predict response to immunotherapy in patients with melanoma, lung cancer, and kidney cancer.
FDA/CDC
New lipid-lowering drug earns FDA approval
News
Variants in common genes linked to endometrial cancer risk
Researchers identified 24 single-nucleotide polymorphisms – in genes that play roles in transcriptional regulation, cell survival, and estrogen...